Jump to navigation

Draft pandemic treaty could force Big Pharma to share vaccines with developing countries

Major battles lie ahead as negotiations on a new treaty to set rules for production and distribution of life-saving drugs

Negotiations on protocols for a global and national level pandemic response have started with the World Health Organization's (WHO) Intergovernmental Negotiating Body's (INB) publication of a 'zero-draft' of a new pandemic treaty last week.

The draft states that the WHO is 'deeply concerned by the gross inequities' of supply, production and access to Covid-19 vaccines. Its proposal to reserve at least 20% of any tests, vaccines or treatments for use in poorer countries is likely to prompt major pushback from pharmaceutical giants.

Civil society groups say the treaty should compel governments to commit to sharing medical technology and knowhow. It also states that the intellectual property rules that uphold pharmaceutical company monopolies must be waived automatically when a health emergency is declared.

This points to the need for clear enforcement of the treaty which raises another raft of diplomatic questions. The WHO insists the treaty should be legally binding.

The draft cites the backdrop to its recommendations as the 'catastrophic failure of the international community in showing solidarity and equity in response to the novel Covid-19 pandemic'. The final draft is set to be presented at the World Health Assembly in 2024.

Other proposals in the draft include strengthening and sustaining capacities of health systems, cooperation for sustainable and predictable financing, and raising pandemic and public health literacy for pandemic prevention, preparedness, response and recovery.

It also calls for the establishment of the WHO Global Pandemic Supply Chain and Logistics Network to promote production and transfer of technology and know-how.

This network would boost research and development capacities and establish a Pathogen Access Benefit-Sharing System (PABS) to ensure equitable and timely sharing of pathogens with pandemic potential and genomic sequences.



Related Articles

Kudos to the health-workers

Despite grandstanding by some senior politicians, it is the doctors and nurses who are winning public support in the fight against the coronavirus

Criticisms are mounting about the lack of a coherent national strategy to manage the coronavirus pandemic. The missing piece is effective leadership from the national task force, under...


Jab race hits new snag

Slow and unpredictable supplies and donations continue to disrupt the roll-out of Covid-19 vaccines in Africa. According to the World Health Organization, most vaccine donations have been 'ad...


Nkengasong sings

The African Union's decision to grant autonomy to the African Centres for Disease Control and Prevention marks a victory for its highly regarded director John Nkengasong, who had...


Whose cure is it anyway?

Industrialised countries are defending funding research to find a vaccine for Covid-19 out of Official Development Assistance funds against a possible challenge from the Organisation for Economic Co-operation...